Anshu Raj Dahal
Nepal's pharmaceutical market size is equivalent to 250 U.S. million, according to the APPON (Association of Pharmaceutical Producers of Nepal, 2010). Nepalese pharma market is less regulated. DDA (Department of Drug Administration) has lesser resource and tools to monitor quality of such an import-influx. The joint effort of three-parties; local companies, medical practitioners plus the retailers pushed by sales representative, has remained successful in replacing foreign brands from the market. Doctors have enough brands to remember and write. Those sales personnel who builds relationship and constantly follows for feed-back gets prescription. It is unnecessary that all the prescription give businesses. The problem of product substitution at the retailer is yet another challenge. That is the same reason sales representative are in constant contact with the retailers for market feedback.
இந்தக் கட்டுரையைப் பகிரவும்